Compounds > flubendazole
Page last updated: 2024-08-23

flubendazole and Melanoma

flubendazole has been researched along with Melanoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Corley, S; Hossain, MJ; Khachigian, LM; Li, Y; O'Meara, C; Quagliata, L; Wilkins, MR; Wu, B1
Rudolf, E; Rudolf, K1
Čáňová, K; Rozkydalová, L; Rudolf, E; Vokurková, D1
Acharya, G; Elahy, M; Khachigian, LM; Li, Y; Xin, H1

Other Studies

4 other study(ies) available for flubendazole and Melanoma

ArticleYear
Flubendazole inhibits PD-1 and suppresses melanoma growth in immunocompetent mice.
    Journal of translational medicine, 2023, 07-14, Volume: 21, Issue:1

    Topics: Animals; B7-H1 Antigen; Cell Line, Tumor; Humans; Melanoma; Mice; Mice, Inbred C57BL; Programmed Cell Death 1 Receptor; Skin Neoplasms; Transcription Factor AP-1

2023
An analysis of mitotic catastrophe induced cell responses in melanoma cells exposed to flubendazole.
    Toxicology in vitro : an international journal published in association with BIBRA, 2020, Volume: 68

    Topics: Aged; Antineoplastic Agents; Apoptosis; Autophagy; Cell Cycle; Cell Line, Tumor; Cytochromes c; Humans; JNK Mitogen-Activated Protein Kinases; Male; Mebendazole; Melanoma; Membrane Potential, Mitochondrial; Middle Aged; Mitosis; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53

2020
Flubendazole induces mitotic catastrophe and apoptosis in melanoma cells.
    Toxicology in vitro : an international journal published in association with BIBRA, 2018, Volume: 46

    Topics: Antinematodal Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Mebendazole; Melanoma; Mitosis

2018
The anthelmintic flubendazole blocks human melanoma growth and metastasis and suppresses programmed cell death protein-1 and myeloid-derived suppressor cell accumulation.
    Cancer letters, 2019, 09-10, Volume: 459

    Topics: Animals; Antinematodal Agents; Antineoplastic Agents; Cell Growth Processes; Cell Line, Tumor; Female; Humans; Lung Neoplasms; Mebendazole; Melanoma; Mice; Mice, SCID; Myeloid-Derived Suppressor Cells; Neoplasm Metastasis; Neovascularization, Pathologic; Programmed Cell Death 1 Receptor; Random Allocation; STAT3 Transcription Factor; Xenograft Model Antitumor Assays

2019